TEAS RF New Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88129597

Filing Date: 09/24/2018

To the Commissioner for Trademarks:

MARK: RSM (Standard Characters, see mark)
The literal element of the mark consists of RSM.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, Finch Therapeutics, Inc., a corporation of Delaware, having an address of
      200 Inner Belt Road, Suite 400
      Somerville, Massachusetts 02143
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceuticals used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; dietary and nutritional supplements; nutritional food additives for medical purposes; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; cultures and preparations of microorganisms for medical and veterinary purposes; Pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceuticals in the nature of cultures of microorganisms for medical and veterinary use.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 042:  Research and development of microbiologics, immunotherapeutics, and other therapeutic agents; Development of pharmaceuticals, diagnostics, food additives, dietary supplements, medical foods, foods for special dietary use; Scientific research and development services relating to foods and dietary supplements; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


The applicant's current Attorney Information:
      Rachelle A. Dubow, Esq. and the firm of Morgan, Lewis & Bockius LLP, RON N. DREBEN, KAREN A. BUTCHER, ANITA B. POLOTT, CAROLE R. KLEIN, JOSEPH E. WASHINGTON, KRISTIN H. ALTOFF, DANA S. GROSS, DANIEL S. MARKS, JANE W. WISE, SETH A. RAPPAPORT, CONSTANCE BOUTSIKARIS and REBECCA E. MCDOUGALL, members of the District of Columbia Bar and RACHEL FERTIG, member of the New York Bar, all located at 1111 Pennsylvania Ave., NW, Washington, D.C. 20004, ROCHELLE D. ALPERT, CARLA B. OAKLEY and SHARON R. SMITH, members of the California Bar, PETER BYRNE, member of the California Bar and Massachusetts Bar, and GENE K. PARK, member of the District of Columbia Bar, all located at One Market, Spear Street Tower, San Francisco, California 94105, ANDREW J. GRAY IV, member of the California Bar, located at 1400 Page Mill Road, Palo Alto, California 94304, and RACHELLE A. DUBOW, DAVID O. JOHANSON and SARAH PAIGE, members of the Massachusetts Bar, all located at One Federal Street, Boston, Massachusetts 02110, all of whom should receive correspondence of Morgan, Lewis & Bockius LLP
      Attn: TMSU
      One Federal Street
      Boston, Massachusetts 02110
      United States
      617-951-8939(phone)
      6179518736(fax)
      trademarks@morganlewis.com (authorized)
The attorney docket/reference number is 112933-0009.

The applicant's current Correspondence Information:

Rachelle A. Dubow, Esq.

Morgan, Lewis & Bockius LLP

Attn: TMSU       One Federal Street

Boston, Massachusetts 02110

617-951-8939(phone)

6179518736(fax)

trademarks@morganlewis.com;rachelle.dubow@morganlewis.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Benjamin Enerson/   Date: 09/24/2018
Signatory's Name: Benjamin Enerson
Signatory's Position: VP & General Counsel
Payment Sale Number: 88129597
Payment Accounting Date: 09/25/2018

Serial Number: 88129597
Internet Transmission Date: Mon Sep 24 16:46:40 EDT 2018
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XXX-2018092416464095
6406-88129597-610d2ffdab5b381e6e9958912f
5b28878b27983860be3236fd7efb8a125233946-
DA-4037-20180924111503659137